Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Johannsen

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 27, 2010
Magnetic nanoparticle hyperthermia for prostate cancerManfred Johannsen, Burghard Thiesen, Peter Wust, et al.
Expert Review of Anticancer Therapy|October 31, 2006
Allogeneic stem cell transplantation for patients with metastatic renal cell carcinomaJan Roigas, Manfred Johannsen, Martin Ringsdorf, et al.
Surgical Innovation|December 25, 2009
Laparoscopic partial nephrectomy using FloSeal for hemostasis: technique and experiences in 102 patientsAndreas H Wille, Manfred Johannsen, Kurt Miller, et al.
The Journal of Urology|October 30, 2010
The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinomaKatharina Frey, Christoph Schliemann, Kathrin Schwager, et al.
Cancer Science|April 22, 2008
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomasAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
Journal of Cancer Research and Clinical Oncology|August 21, 2020
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)Philipp Ivanyi, Carsten Grüllich, Nils Kroeger, et al.
BMC Molecular Biology|June 15, 2007
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCRMonika Jung, Azizbek Ramankulov, Jan Roigas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomasFlorian R Fritzsche, Beibei Oelrich, Manfred Johannsen, et al.
Cancer Letters|May 28, 2008
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinomaAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgerySabine Brookman-May, Manfred Johannsen, Matthias May, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 27, 2010
Magnetic nanoparticle hyperthermia for prostate cancerManfred Johannsen, Burghard Thiesen, Peter Wust, et al.
Expert Review of Anticancer Therapy|October 31, 2006
Allogeneic stem cell transplantation for patients with metastatic renal cell carcinomaJan Roigas, Manfred Johannsen, Martin Ringsdorf, et al.
Surgical Innovation|December 25, 2009
Laparoscopic partial nephrectomy using FloSeal for hemostasis: technique and experiences in 102 patientsAndreas H Wille, Manfred Johannsen, Kurt Miller, et al.
The Journal of Urology|October 30, 2010
The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinomaKatharina Frey, Christoph Schliemann, Kathrin Schwager, et al.
Cancer Science|April 22, 2008
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomasAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
Journal of Cancer Research and Clinical Oncology|August 21, 2020
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)Philipp Ivanyi, Carsten Grüllich, Nils Kroeger, et al.
BMC Molecular Biology|June 15, 2007
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCRMonika Jung, Azizbek Ramankulov, Jan Roigas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomasFlorian R Fritzsche, Beibei Oelrich, Manfred Johannsen, et al.
Cancer Letters|May 28, 2008
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinomaAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgerySabine Brookman-May, Manfred Johannsen, Matthias May, et al.
Pageof 6